Dr. Roberto Gabach: “If it is difficult you plan, if it is impossible you try”
Dr. Gabach, our director & manager of New Projects, analyzes the present and gives us a preview of the future of Amarin and the transdermal market.
Sergio Lucero: “Amarin differentiates itself by respecting all the rules and being flexible in dealing”
What makes it possible for Amarin, a small player, to compete in the big leagues of the transdermal market? Here are the reasons in the voice of our Director & CEO, Sergio Lucero.
Dr. Francisco Stefano: “The truth is not always what you believe, but what you find”
A review of the evolution of the transdermal market in the voice of Dr. Francisco Stefano, our director. Challenges of science and passion as protagonists.
Alzheimer’s Month
On September 21, World Alzheimer’s Day is commemorated, in the context of World Alzheimer’s Month.
Opportunities in an evolving market
In a first and superficial approach to the main market indicators, and in line with some publications, we can have feeling of witnessing the twilight of one the most innovative pharmaceutical forms in the industry,..
2020 EMA New Drug Therapy Approvals – An Overview
Although in 2020 health agencies worldwide were mostly focused in managing the COVID-19 public health emergency, EMA recommended 97 medicines for marketing authorisation. That’s not just a number.
World Parkinson’s Day
In 1997, the World Health Organization declared April 11th as World Parkinson’s Day, coinciding with the anniversary of the birth of James Parkinson, a British neurologist who, in 1817, discovered what he called ‘agitating paralysis’ and which we know today as Parkinson’s disease.
Aspects to be evaluated when hiring a developer of transdermal pharmaceutical products
In the pharmaceutical industry, product development is a priority and foundational stage. It is not my intention in this article to refer to the development of new molecules, which is restricted to large companies or companies that can obtain significant funds..
2020 FDA New Drug Therapy Approvals – An Overview
Despite the well-known challenges faced during 2020 due to the COVID-19 public health emergency, the FDA managed to review and approve 53 new drug therapies. That’s not just a number.
Topical and Transdermal Drug Products: Making the difference through transdermal delivery systems
The terms topical and transdermal are sometimes confused. The fact that, by definition, all medications applied onto the skin are topical -that is, applied to the skin surface- may lead to such misconception…